Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial

PURPOSE: To report on the Stereotactic Body Radiation Therapy (SBRT) credentialing experience during the Phase III Ontario Clinical Oncology Group (OCOG) LUSTRE trial for stage I non-small cell lung cancer. METHODS: Three credentialing requirements were required in this process: (a) An institutional...

Descripción completa

Detalles Bibliográficos
Autores principales: Swaminath, Anand, Wierzbicki, Marcin, Parpia, Sameer, Kundapur, Vijayananda, Faria, Sergio, Ahmed, Naseer, Bujold, Alexis, Hirmiz, Khalid, Owen, Timothy, Leong, Nelson, Ramchandar, Kevin, Filion, Edith, Lau, Harold, Thompson, Robert, Yaremko, Brian, Gabos, Zsolt, Mehiri, Selma, Wright, James R., Tsakiridis, Theodoros K., Cline, Kathryn, Whelan, Timothy J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579727/
https://www.ncbi.nlm.nih.gov/pubmed/36275452
http://dx.doi.org/10.1016/j.ctro.2022.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579727/
https://www.ncbi.nlm.nih.gov/pubmed/36275452
http://dx.doi.org/10.1016/j.ctro.2022.10.002

Ejemplares similares